Citigroup’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-122,195
Closed -$3.31M 8111
2015
Q4
$3.31M Buy
122,195
+3,152
+3% +$81.2K ﹤0.01% 2075
2015
Q3
$2.6M Buy
119,043
+41,861
+54% +$1.07M ﹤0.01% 2228
2015
Q2
$2.2M Buy
77,182
+64,388
+503% +$1.88M ﹤0.01% 2431
2015
Q1
$349K Buy
12,794
+4,941
+63% +$136K ﹤0.01% 4060
2014
Q4
$208K Sell
7,853
-16,614
-68% -$486K ﹤0.01% 4658
2014
Q3
$738K Sell
24,467
-8,130
-25% -$252K ﹤0.01% 3235
2014
Q2
$1.03M Sell
32,597
-77,091
-70% -$2.45M ﹤0.01% 2957
2014
Q1
$3.55M Buy
109,688
+95,055
+650% +$3.33M ﹤0.01% 1961
2013
Q4
$532K Sell
14,633
-6,881
-32% -$267K ﹤0.01% 3741
2013
Q3
$837K Buy
21,514
+7,526
+54% +$303K ﹤0.01% 3032
2013
Q2
$523K Buy
+13,988
New +$552K ﹤0.01% 3448

Other funds holding MR

Citigroup's MR Position: Q1 2016 in Review

Citigroup sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 122,195 shares — an estimated $3.31M sold.

Citigroup first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $3.55M in Q1 2014. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Citigroup reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Citigroup sold 122,195 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $3.31M.
  • Citigroup first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
  • Citigroup's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $3.55M in Q1 2014.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Citigroup's 13F filing for Q1 2016, filed 13 May 2016.